Impact of COVID-19 acute respiratory disease on the risk factors attributed to cancer patients.
Toxicol Rep
; 9: 46-52, 2022.
Article
en En
| MEDLINE
| ID: mdl-34934636
AACR, American Association of Cancer Research; ASCO, American Society of Clinical Oncology; Acute respiratory disease; CCC-19, COVID-19 and Cancer Consortium; CDs, Communicable diseases; COVID-19; COVID-19 ARD, acute respiratory disease; COVID-19, coronavirus disease 2019; Cancer; Communicable diseases; ESCA, Esophageal carcinoma; ESMO, European Society for Medical Oncology; Health; ICU, Intensive Care Unit; KICH, Kidney Chromophobe; KIRP, Kidney renal papillary cell carcinoma; LUAD, Lung adenocarcinoma; PCR, Real-time Polymerase Chain Reaction; PRAD, Prostate adenocarcinoma; Risk factors; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; UCEC, Uterine Corpus Endometrial Carcinoma; WHO, World Health Organization
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Toxicol Rep
Año:
2022
Tipo del documento:
Article
País de afiliación:
Irán
Pais de publicación:
Irlanda